197 related articles for article (PubMed ID: 7595915)
1. Further evidence for the efficacy of imidocarb dipropionate in the treatment of Ehrlichia canis infection.
Matthewman LA; Kelly PJ; Brouqui P; Raoult D
J S Afr Vet Assoc; 1994 Sep; 65(3):104-7. PubMed ID: 7595915
[TBL] [Abstract][Full Text] [Related]
2. Failure of imidocarb dipropionate to clear experimentally induced Ehrlichia canis infection in dogs.
Eddlestone SM; Neer TM; Gaunt SD; Corstvet R; Gill A; Hosgood G; Hegarty B; Breitschwerdt EB
J Vet Intern Med; 2006; 20(4):840-4. PubMed ID: 16955806
[TBL] [Abstract][Full Text] [Related]
3. Serological evidence of Ehrlichia canis in dogs in southern Italy.
Buonavoglia D; Sagazio P; Gravino EA; De Caprariis D; Cerundolo R; Buonavoglia C
New Microbiol; 1995 Jan; 18(1):83-6. PubMed ID: 7760762
[TBL] [Abstract][Full Text] [Related]
4. Western blot and indirect fluorescent antibody testing for antibodies reactive with Ehrlichia canis in sera from apparently healthy dogs in Zimbabwe.
Matthewman LA; Kelly PJ; Mahan SM; Semu D; Tagwira M; Bobade PA; Brouqui P; Mason PR; Raoult D
J S Afr Vet Assoc; 1993 Sep; 64(3):111-5. PubMed ID: 8176682
[TBL] [Abstract][Full Text] [Related]
5. Attempted treatment of canine ehrlichiosis with imidocarb dipropionate.
Van Heerden J; Van Heerden A
J S Afr Vet Assoc; 1981 Sep; 52(3):173-5. PubMed ID: 7310786
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis.
Dawson JE; Ewing SA
Am J Vet Res; 1992 Aug; 53(8):1322-7. PubMed ID: 1510307
[TBL] [Abstract][Full Text] [Related]
7. Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs based on parasitological and molecular evaluation methods.
Sasanelli M; Paradies P; Greco B; Eyal O; Zaza V; Baneth G
Vet Parasitol; 2010 Aug; 171(3-4):194-9. PubMed ID: 20444549
[TBL] [Abstract][Full Text] [Related]
8. Ehrlichial infection in Cameroonian canines by Ehrlichia canis and Ehrlichia ewingii.
Ndip LM; Ndip RN; Esemu SN; Dickmu VL; Fokam EB; Walker DH; McBride JW
Vet Microbiol; 2005 Nov; 111(1-2):59-66. PubMed ID: 16181750
[TBL] [Abstract][Full Text] [Related]
9. Recombinant major antigenic protein 2 of Ehrlichia canis: a potential diagnostic tool.
Alleman AR; McSherry LJ; Barbet AF; Breitschwerdt EB; Sorenson HL; Bowie MV; Bélanger M
J Clin Microbiol; 2001 Jul; 39(7):2494-9. PubMed ID: 11427559
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal quantification of Ehrlichia canis in experimental infection with comparison to natural infection.
Baneth G; Harrus S; Ohnona FS; Schlesinger Y
Vet Microbiol; 2009 May; 136(3-4):321-5. PubMed ID: 19128893
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of rifampicin in the treatment of experimental acute canine monocytic ehrlichiosis.
Theodorou K; Mylonakis ME; Siarkou VI; Leontides L; Koutinas AF; Koutinas CK; Kritsepi-Konstantinou M; Batzias G; Flouraki E; Eyal O; Kontos V; Harrus S
J Antimicrob Chemother; 2013 Jul; 68(7):1619-26. PubMed ID: 23475646
[TBL] [Abstract][Full Text] [Related]
12. Experimental Ehrlichia canis infection in the dog does not cause immunosuppression.
Hess PR; English RV; Hegarty BC; Brown GD; Breitschwerdt EB
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):117-25. PubMed ID: 16169601
[TBL] [Abstract][Full Text] [Related]
13. First isolation and molecular characterization of Ehrlichia canis in Spain.
Aguirre E; Sainz A; Dunner S; Amusategui I; López L; Rodríguez-Franco F; Luaces I; Cortés O; Tesouro MA
Vet Parasitol; 2004 Nov; 125(3-4):365-72. PubMed ID: 15482892
[TBL] [Abstract][Full Text] [Related]
14. Experimental inoculation of beagle dogs with Ehrlichia species detected from Ixodes ovatus.
Watanabe M; Oikawa T; Hiraoka H; Kaneko N; Itamoto K; Mizuno T; Okuda M; Inokuma H
Vet Parasitol; 2006 Mar; 136(2):147-54. PubMed ID: 16309840
[TBL] [Abstract][Full Text] [Related]
15. Ehrlichia canis in dogs experimentally infected, treated, and then immune suppressed during the acute or subclinical phases.
Sato M; Veir JK; Shropshire SB; Lappin MR
J Vet Intern Med; 2020 May; 34(3):1214-1221. PubMed ID: 32267035
[TBL] [Abstract][Full Text] [Related]
16. Results from an indirect fluorescent antibody test using three different strains of Ehrlichia canis.
Aguirre E; Ayllón T; Sainz A; Amusategui I; Villaescusa A; Rodríguez-Franco F; Tesouro MA
Vet J; 2009 Nov; 182(2):301-5. PubMed ID: 18760641
[TBL] [Abstract][Full Text] [Related]
17. [Incidence and seroprevalence of canine ehrlichiosis in the Medjez El Bab region (northwestern Tunisia during 1994, 1995 and 1996].
Ghorbel A; Ben Ayed M; Diwani E; Ghram A; Landolsi F; Messaadi L; Zrelli S; Chabchoub A
Arch Inst Pasteur Tunis; 2001; 78(1-4):41-7. PubMed ID: 14658238
[TBL] [Abstract][Full Text] [Related]
18. Reisolation of Ehrlichia canis from blood and tissues of dogs after doxycycline treatment.
Iqbal Z; Rikihisa Y
J Clin Microbiol; 1994 Jul; 32(7):1644-9. PubMed ID: 7929751
[TBL] [Abstract][Full Text] [Related]
19. Investigation of renal protein loss in dogs with acute experimentally induced Ehrlichia canis infection.
Codner EC; Maslin WR
Am J Vet Res; 1992 Mar; 53(3):294-9. PubMed ID: 1595954
[TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia.
Dawson JE; Biggie KL; Warner CK; Cookson K; Jenkins S; Levine JF; Olson JG
Am J Vet Res; 1996 Aug; 57(8):1175-9. PubMed ID: 8836370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
